Symphony Financial’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Symphony Financial's AMGN Position: Q2 2026 in Review
Symphony Financial increased its Amgen (AMGN) stake by 7.4% in Q2 2026, buying an estimated $211K and bringing the position to 8,993 shares worth $3.24M. The position accounts for 0.35% of the portfolio, ranked #62.
Symphony Financial first reported a position in AMGN in Q1 2022 and has held it in 16 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Symphony Financial held 8,993 shares of Amgen worth $3.24M as of Q2 2026.
- Symphony Financial bought 617 Amgen shares in Q2 2026, an estimated $211K.
- Amgen made up 0.35% of Symphony Financial's portfolio in Q2 2026, its #62 holding.
- Symphony Financial first reported a position in Amgen in Q1 2022 and has held it in 16 quarters since.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Symphony Financial's 13F filing for Q2 2026, filed 4 Aug 2026.